2
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

The metabolism of niridazole (AMBILHARR) in man

II. Investigations on patients suffering from clinically advanced forms of Schistosoma mansoni infection

, , &
Pages 383-393 | Received 21 Jul 1969, Published online: 15 Mar 2016

REFERENCES

  • Coutinho, A. D., and Trindade Barretto, F. (1969). Treatment of hepatosplenic schistosomiasis mansoni with niridazole: relationships among liver function, effective dose, and side effects. Arm. N.Y. Acad. Sci., 160, 612.
  • Faigle, J. W., Blair, D. M., Clarke, V. de V., Davidson, L. A. G., Dukes, D. C., and Keberle, H. (1970). The metabolism of niridazole (AmbilharR) in man. I. Investigations on patients suffering from clinically mild forms of Schistosoma haematobium and Schistosoma mansoni infection. Ann. trop. Med. Parasit., 64, 373.
  • Faigle, J. W., Blair, D. M., Clarke, V. de V., Davidson, L. A. G., Dukes, D. C., and Keberle, H. (1966). The metabolic fate of CIBA 32,644-Ba. Acta trop., 9, Suppl., 8.
  • Faigle, J. W., Blair, D. M., Clarke, V. de V., Davidson, L. A. G., Dukes, D. C., and Keberle, H. (1969). Metabolism of niridazole in various species including man. Ann. N.Y. Acad. Sci., 160, 544.
  • Fontanilles, F. (1969). Risks versus benefits in antischistosomal therapy. Ann. N. Y. Acad. Sci., 160, 811.
  • Lambert, C. R. (1966). Nouveau traitement des schistosomiases et de l'amibiase, le CIBA 32,644-Ba. Acta trop., 23, 1.
  • Martins Da Rocha, R., and Gil, F. B. (1966). Essais préliminaires sur l'élimination du CIBA 32,644-Bamarqué C14. Acta trop., 9, Suppl., 23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.